Influence, as much as I costs
Syndromes, influenza, flu, true to the cooling with a sore throat and cough which may be present in the spring and in the summer, they did spend out of their own pocket to the italians 1 billion and 187 million in calendar year 2018 for drugs that are not prescription. From November 2018 to 28 February 2019, the expenditure was of about 570 million, according to data supplied by Iqvia, a global provider of healthcare information, innovative technologies, consulting services and clinical research. The part of the lion have made the pharmacies that out of a total of 1 milardo and 187 million euro, have recorded sales for a million and 69 million, while the rest of the otc drugs were purchased in the parapharmacies, and also at the great organized distribution. In 2018, it has been registered an increase in sales of drugs against cough of 5.2% to 322 million euros. In particular, have been spent 150 million euro ( 7,8%) for the sedative for the cough, while expectorants have reached 172 million euros ( 4%). With regards to the products that dominated the market last year, maintains the primacy of the antipyretic-analgesic Paracetamol (acetaminophen). In the period from November 2018 to 28 February 2019, the trend of the sale of drugs for the treatment of flu-like symptoms (self-medication, and drugs without prescription) has registered a slight decline compared to the same period in 2017 and 2018, when the flu season has been more virulent. In fact, in these four months, in the consumption of the whole sector (antipyretics, decongestants, anticough, expectorant, saline solutions, anti-allergic) was highlighted a decline of 0. .2% in the values compared to the same period of 2017 and 2018.
In contrast, the products for sore throat ( 3,6%), saline solutions, nasal ( 3.
.2%), and the products anti-allergic-the-counter ( 10,6%).
On average – according to the analysis of Iqvia – the influenza syndrome in Italy affect every year 9% of the population, with a minimum of 4%, observed in the 2005-2006 season. While in season 2017 and 2018, it is recorded the absolute maximum: 15%. The period of the flu 2018-2019, still partially in progress, was characterized by an initial period of low incidence until the end of December 2018. While the virus is widespread by the beginning of 2019. According to the data of the national surveillance System InfluNet, coordinated by the Istituto Superiore di Sanità, the peak of the epidemic was reached between the end of the month of January and the beginning of February. The infection has affected mainly the age pediatric preschool and schoolchildren and the over-fifties. . .